GLYBERA

Details for Australian Trade Mark No. 1176048 (hide)

Owner Amsterdam Molecular Therapeutics (AMT) Holding N.V.

Convention EM 1 May 2007 005901269

Service Davies Collison Cave

Filing Date 14 May 2007

Classes

Class 5 Pharmaceutical products; biological preparations for use in medical and clinical gene therapy and cell therapy; clinical medical reagents for use in gene therapy, gene diagnosis, and gene testing; pharmaceutical preparations, namely, vaccines for use in gene therapy; gene therapy and prophylaxis products, namely, gene delivery, gene transfer, gene regulation and gene modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, cancer, inflammatory and auto-immune diseases, vascular disorders, and single gene disorders

Event Publications

31 May 2007 Application filed

30 August 2007 Application Accepted

3 January 2008 Trade Mark Registered/Protected

3 January 2008 Registrations/Protected IR Name Amendment and Changes

  The owner's/holder's name has been changed to Amsterdam Molecular Therapeutics (AMT) Holding N.V..

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1176049-ZYAMTIN

1176047-ITAL CAR